Search Results for: clinicaltrials.gov

Stemedica reply to Olbermann interview on Gordie Howe

gordie-howe_001-4_3

The stem cell company Stemedica along with Mexican partner Novastem conducted a stem cell intervention on hockey legend Gordie Howe, who had suffered strokes in 2014. This situation has sparked a lot of discussion and media attention including a recent interview with Stemedica leadership on the Keith Olbermann show on ESPN. For balance and fairness …

Stemedica reply to Olbermann interview on Gordie Howe Read More »

Olbermann Puff Interview on Stemedica & Gordie Howe

Stemedica-Olbermann

The stem cell company Stemedica has made a name for itself in the media lately through hockey legend Gordie Howe, who received a non-FDA approved stem cell “treatment” in Mexico via Stemedica and its partner, Novastem. Howe, known as Mr. Hockey, had several strokes in late 2014 and his health was declining. Stemedica and Novastem …

Olbermann Puff Interview on Stemedica & Gordie Howe Read More »

Response from Stemedica on Stem Cell Treatment of Howe

stemedica

I have heard back from Stemedica on some questions I had on their role in the stem cell intervention done on hockey legend Gordie Howe. I heard from Marcie J. Frank, VP at Stemedica for Investor Relations. I want to thank her for answering the questions and doing so so quickly.   Q: Did Stemedica write the …

Response from Stemedica on Stem Cell Treatment of Howe Read More »

Super Cells exhibit and why we bother with public outreach

Super-Cells

Guest post by Lisa Willemse Last month, on this blog, Paul wrote an article about loopholes in the clinicaltrials.gov database that allows for-profit companies to advertise their “therapies” under the guise of a registered clinical trial. This is a real concern for our community, especially those among us who have recommended the clinicaltrials database as …

Super Cells exhibit and why we bother with public outreach Read More »

Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient

viacyte-encaptra

Chalk up another exciting development for the stem cell and regenerative medicine field in 2014 related to diabetes. It’s been a huge year. (Update: read my Fall 2019 interview with ViaCyte here.) For the first time ever, an ES cell-based device has been transplanted into a diabetic patient. ViaCyte working together with Dr. Robert Henry …

Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient Read More »

Skeptical look at stem cells for baldness: hope vs. hype

Bald-stem

Can stem cells some day cure baldness? This is about more than vanity. Baldness can also be due to a medical condition or a side effect of a treatment of another kind. Many medical procedures such as radiation treatment for brain cancer or chemo as well as medical conditions such as burns or alopecia cause baldness, …

Skeptical look at stem cells for baldness: hope vs. hype Read More »

Duke Launches Large, Debated Stem Cells for Autism Trial

DawsonKurtzberg

Is there real promise of stem cells for autism? At this point the jury remains out on that question, but a growing number of kids are nonetheless getting such “treatments” at for-profit dubious clinics. Academic clinical researchers are interested in this area as well. Still, the potential use of stem cells to treat autism is …

Duke Launches Large, Debated Stem Cells for Autism Trial Read More »

J&J Bets Up to $325 million on Capricor: Big Pharma Stem Cell Move as Predicted for 2014

Big Pharma Giant Johnson & Johnson (J & J; $JNJ) announced today a $12.5 million investment in stem cells & regenerative medicine via the small biotech Capricor ($CAPR) and the potential for the bet to go into the hundreds of millions for the heart disease program. It was only 8 days ago that I made …

J&J Bets Up to $325 million on Capricor: Big Pharma Stem Cell Move as Predicted for 2014 Read More »